Peptides

Cat.No.	Name	Information
M3815	Pasireotide	Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs.
M3624	Boceprevir (EBP 520)	Boceprevir (EBP-520, SCH503034) is an HCV protease inhibitor (Ki=14 nM) for the treatment of hepatitis C virus infection.
M3278	MK-5172 (Grazoprevir)	MK-5172 is a novel NS3/4, a protease inhibitor for chronic HCV infection (Enzyme Ki for genotype1b, 2a, 2b and 3a at ＜0.02, 0.15, 0.02 and 0.7 nM, respectively).
M3274	Pentagastrin	Pentagastrin (ICI-50123) is a synthetic polypeptide that has effects like gastrin when given parenterally.
M2159	Ritonavir	Ritonavir is an HIV protease inhibitor used in the study of HIV infection and AIDS. Ritonavir (ABT 538)
M2152	Carfilzomib	Carfilzomib (PR-171) is an irreversible proteasome inhibitor with an IC50 of <5 nM. Carfilzomib irreverently selectively binds to the active site containing n-terminal threonine of the 20S proteasome and proteolytic core particles of the 26S proteasome.*The compound is unstable in solutions, freshly prepared is recommended.
M1835	Goserelin acetate	Goserelin acetate is an injectable gonadotropin releasing hormone superagonist (GnRH agonist), also known as a luteinizing hormone releasing hormone (LHRH) agonist.
M1808	Telaprevir	Telaprevir (VX-950) is a novel hepatitis C virus (HCV) NS3-4A protease inhibitor with IC50 of < 0.2 μM.
M1601	Dulaglutide (Activated main chain)	Dulaglutide (Activated main chain) is a glucagon-like peptide-1 receptor agonist (GLP-1 agonist) consisting of GLP-1(7-37) covalently linked to an Fc fragment of human IgG4.
M59155	RS17	RS17 is an anti-tumor peptide designed to bind specifically to the CD47 molecule and block the interaction between CD47 and its ligand, SIRPα, on the surface membrane of macrophages.
M59120	Ac-VEID-AFC	Ac-VEID-AFC is a caspase-6 fluorogenic substrate, and can be used in the caspase 6 activity assay.
M59103	123B9	123B9 is a tumor-homing agent, it is also a potent and selective EphA2 agonist with a Kd value of 4.0 μM. 123B9 selectively targets the EphA2 tyrosine kinase receptor ligand-binding domain.
M59101	CCZ01048 TFA	CCZ01048 TFA is an α-MSH analogue, which exhibits high binding affinity to melanocortin 1 receptor (MC1R) with a Ki of 0.31 nM.
M58700	CPN-351 TFA	CPN-351 TFA is a selective pentapeptide antagonist of human NMUR1 with a pA2 of 7.35. CPN-351 TFA can be used for the research of inflammation.
M58677	TMTP1 Peptide	TMTP1 is a 5-amino acid peptide NVVRQ, it can be used for the labeling of malignant in situ and metastatic lesions, and even micro-metastases. TMTP1 specifically bound to the cells of a series of hematological malignancies, including HL60, k562, Jurkat, Raji, El-4 and chronic myeloid leukemia primary cells but not to bone marrow mononuclear cells from healthy subjects. TMTP1, as a novel tumor-homing peptide, can serve as a marker for primary malignant and metastatic lesions.
M58617	BMS-986238	BMS-986238 is a potent macrocyclic peptide PD-L1 inhibitor that contains a fatty acid modification on the surface of BMS-986238, which allows it to bind reversibly to serum albumin, thereby significantly prolonging circulation time in vivo. BMS-986238 possesses picomolar levels of PD-L1 binding affinity.
M58582	Lariocidin
M58456	Allo-aca	Allo-aca, a leptin peptidomimetic, is a potent, specific leptin receptor antagonist peptide. Allo-aca blocks leptin signaling and action in numerous in vitro and in vivo models.
M58195	FK 565	FK 565 is an immunoactive peptide and a nucleotide-binding oligomerization domain (Nod)-1 ligand agonist.
M57278	GluN1 (356-385)	GluN1 (356-385) is an antigenic peptide against N-methyl-D-aspartate receptor (NMDAR) encephalitis. GluN1 (356-385) has the effect of reducing the density of surface NMDAR clusters in hippocampal neurons.

Catalog

By Signaling Pathways

By Product Type

Signaling Pathways

Peptides

Get to Know Us

Customer Support

Resources

Contact Us